Zhen Qin is an experienced professional in Clinical Development and Regulatory Writing, currently serving as the Associate Director of Clinical Regulatory Writing at AstraZeneca since 2025. Previously, Zhen held senior leadership roles at CStone Pharmaceuticals, including Senior Director of Clinical Strategy and Development, and served as an Entrepreneur in Residence at Lilly Asia Ventures. Zhen's career also includes significant positions at BeiGene, GSK, and BioDuro, contributing to advancements in clinical research through data-driven insights and collaboration. Zhen earned a degree from Tsinghua University between 1997 and 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices